4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001170918-07-000191
Options or other derivatives
- Chief Marketing Officer sold 53,538.86 shares
- Chief Marketing Officer acquired 11,250,000 shares (grant or award)
- Chief Marketing Officer disposed of 174,328,512 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| WALKER SCOTT Chief Marketing Officer | 2007-03-08 | Other disposition · Options (Right to Buy) | −174,328,512 | 0 | D | ||
| WALKER SCOTT Chief Marketing Officer | 2007-03-08 | Grant or award · Options (Right to Buy) | +11,250,000 | 11,250,000 | D | ||
| WALKER SCOTT Chief Marketing Officer | 2007-03-08 | Sale · Series C Convertible Preferred Stock | −53,538.86 | 108,039.14 | D | ||
Loading xslF345X02/sam07-073_ex.xml…